What is Abbott India Limited's (ABBOTINDIA.NS) StockRank?

MoatMap's StockRank for Abbott India Limited (ABBOTINDIA.NS) is 79/100, with a Buy signal. This is a composite score combining Quality (84), Value (31), and Momentum (59) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Abbott India Limited have an economic moat?

Abbott India Limited (ABBOTINDIA.NS) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Abbott India Limited a buy, hold, or sell?

MoatMap's current signal for Abbott India Limited (ABBOTINDIA.NS) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Abbott India Limited in?

Abbott India Limited (ABBOTINDIA.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ABBOTINDIA.NS

BuyPremium Grower

Abbott India Limited · Healthcare · India · $5.7B · Avg Vol: $2M/d

StockRank

Get insider-trade alerts

P/E (TTM)

33.2x

ROE

32.5%

D/E

0.0x

Dividend %

2.6%

COMPANY DESCRIPTION

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin...

FINANCIAL SUMMARY (INR)

Year	2023	2024	2025	2026	CAGR	TTM
Revenue	53.5B	58.5B	64.1B	69.3B	9.0%	70.3B
EPS (INR)	446.78	565.28	665.62	730.36	17.8%	761.57
Shares	21.2M	21.2M	21.2M	21.2M	0.0%	21.2M
Debt	1.1B	832.3M	2.0B	1.7B	15.0%	1.7B
Equity	31.9B	37.0B	42.3B	47.7B	14.4%	—
Op CF	8.9B	12.1B	10.1B	13.2B	13.9%	13.2B
Inv CF	-1.5B	-4.2B	1.8B	-3.7B	—	—
Fin CF	-6.4B	-7.4B	-9.3B	-10.7B	—	—

Loading 1Y...

PRICE (1Y)-9.1%

SMA 50SMA 200

$264.33

RSI (14)

29.4

52W High

$324.02

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

43.4%98.2

ROE

32.5%95.2

GP/Assets

50.9%87.4

Op. Margin

27.7%90.2

FCF/Assets

19.7%96.3

Piotroski

549.3

Int. Cover

50.0x89.2

D/E Ratio

0.04x74.5

Current Ratio

2.55x49.1

Value

P/E (TTM)

33.2x36.1

EV/EBITDA

27.1x23.6

P/FCF

42.6x34.4

P/B

11.2x10.4

P/S

7.7x31.0

Div Yield

2.6%62.2

Momentum

52W High %

82%69.4

RS 6M

0%65.5

SMA 50/200

1.01x59.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+19%33.8

Q Growth

17%53.0

FUNDAMENTALS

Market Cap

$5.7B

P/E (Forward)

27.8x

Gross Margin

47.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ABBOTINDIA.NS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ABBOTINDIA.NS	Abbott India Limited(you)	$5.7B	79	Buy
AJANTPHARM.NS	Ajanta Pharma Limited	$4.7B	79	Buy
EMCURE.NS	Emcure Pharmaceuticals Limited	$3.9B	81	Strong Buy
GLAND.NS	Gland Pharma Limited	$5.1B	88	Strong Buy
ALKEM.NS	Alkem Laboratories Limited	$6.5B	69	Buy
IPCALAB.NS	Ipca Laboratories Limited	$5.3B	91	Strong Buy
LAURUSLABS.NS	Laurus Labs Limited	$11.1B	75	Buy
GLENMARK.NS	Glenmark Pharmaceuticals Limited	$7.4B	94	Strong Buy
MANKIND.NS	Mankind Pharma Limited	$10.1B	69	Buy
AUROPHARMA.NS	Aurobindo Pharma Limited	$10.3B	91	Strong Buy

Peer medians: ROE 11.8% · P/E 42.8x · Gross margin 59.4%

Abbott India Limited (ABBOTINDIA.NS): Stock Score Summary

Abbott India Limited (ABBOTINDIA.NS) has a MoatMap StockRank of 79/100 based on Quality (84/100), Value (31/100), and Momentum (59/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price	$264.33
Market Cap	$5.7B
P/E (TTM)	33.24
P/E (Forward)	27.84
Price/Book	11.23
Return on Equity	32.5%
Return on Invested Capital	43.4%
Debt/Equity	0.04x
Gross Margin	47.2%
Operating Margin	27.7%
Revenue Growth	4.3%
Dividend Yield	2.6%
Free Cash Flow	$134M

Abbott India Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Abbott India Limited’s (ABBOTINDIA.NS) StockRank?: MoatMap’s StockRank for Abbott India Limited (ABBOTINDIA.NS) is 79/100, with a Buy signal. It is a composite of Quality (84), Value (31), and Momentum (59) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Abbott India Limited have an economic moat?: Abbott India Limited (ABBOTINDIA.NS) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Abbott India Limited a buy, hold, or sell?: MoatMap’s current signal for Abbott India Limited (ABBOTINDIA.NS) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Abbott India Limited in?: Abbott India Limited (ABBOTINDIA.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).